Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel.
Avni-Biron I, Bar-Gil Shitrit A, Koslowsky B, Levartovsky A, Kopylov U, Weisshof R, Aviv Cohen N, Maharshak N, Hovel D, Israeli E, Naftali T, Goren I, Snir Y, Ollech JE, Banai-Eran H, Broitman Y, Sharar-Fischler T, Dotan I, Yanai H. Avni-Biron I, et al. Among authors: koslowsky b. Dig Liver Dis. 2022 Feb;54(2):192-197. doi: 10.1016/j.dld.2021.11.009. Epub 2021 Dec 7. Dig Liver Dis. 2022. PMID: 34887214
Inflammatory bowel disease: an emergent disease among Ethiopian Jews migrating to Israel.
Bar-Gil Shitrit A, Koslowsky B, Kori M, Paz K, Adar T, Israeli E, Ben-Horin S, Berdichevski T, Coscas D, Gal E, Odes S, Shaul R, Ben-Ya'acov A, Goldin E. Bar-Gil Shitrit A, et al. Among authors: koslowsky b. Inflamm Bowel Dis. 2015 Mar;21(3):631-5. doi: 10.1097/MIB.0000000000000311. Inflamm Bowel Dis. 2015. PMID: 25581835 Clinical Trial.
Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
Kopylov U, Ron Y, Avni-Biron I, Koslowsky B, Waterman M, Daher S, Ungar B, Yanai H, Maharshak N, Ben-Bassat O, Lichtenstein L, Bar-Gil Shitrit A, Israeli E, Schwartz D, Zittan E, Eliakim R, Chowers Y, Ben-Horin S, Dotan I. Kopylov U, et al. Among authors: koslowsky b. Inflamm Bowel Dis. 2017 Mar;23(3):404-408. doi: 10.1097/MIB.0000000000001039. Inflamm Bowel Dis. 2017. PMID: 28178003
Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
Koslowsky B, Grisaru-Granovsky S, Livovsky DM, Milgrom Y, Goldin E, Bar-Gil Shitrit A. Koslowsky B, et al. Inflamm Bowel Dis. 2018 Jul 12;24(8):1826-1832. doi: 10.1093/ibd/izy081. Inflamm Bowel Dis. 2018. PMID: 29788306
Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.
Kopylov U, Avni-Biron I, Ron Y, Koslowsky B, Waterman M, Daher S, Ungar B, Schwartz D, Zittan E, Openhaim M, Yanai H, Maharshak N, Bar Gil Shitrit A, Naftali T, Eliakim R, Chowers Y, Ben-Horin S, Dotan I. Kopylov U, et al. Among authors: koslowsky b. Dig Liver Dis. 2019 Jan;51(1):68-74. doi: 10.1016/j.dld.2018.07.040. Epub 2018 Aug 10. Dig Liver Dis. 2019. PMID: 30172649 Clinical Trial.
44 results